Alert

Follow us

And stay informed in real time of the latest News!

Results for ASCO18

Video

Cleveland Clinic MD
CleClinicMD
familial melanoma diagnosis can signal higher risk for other cancers asco18
Familial melanoma diagnosis can signal higher risk for other cancers. #ASCO18
Medscape
Medscape
@Medscape 10 months
high intensity exercise can improve cancer survivor mortality by as much as 40 asco18
High intensity exercise can improve cancer survivor mortality by as much as 40%: https://t.co/0FmttOWh0J #ASCO18
Cleveland Clinic MD
CleClinicMD
a phase 2 trial demonstrates promising results in patients with glioblastoma who take an immunotherapy vaccine
A phase 2 trial demonstrates promising results in patients with glioblastoma who take an immunotherapy vaccine: #ASCO18
Logo
ASCO
ASCO
@ASCO 11 months
asco18 abstracts now available
#ASCO18 abstracts now available: https://t.co/ded3rN0Fke
Logo
Cleveland Clinic MD
CleClinicMD
a phase 3 clinical trial of a new therapy for metastatic renal cell carcinoma shows promising results asco18
A phase 3 clinical trial of a new therapy for metastatic renal cell carcinoma shows promising results. #ASCO18
Bristol-Myers Squibb
bmsnews
how much do you know about the potential role of immune biomarkers in immunooncology take a moment to find out
How much do you know about the potential role of immune #biomarkers in #ImmunoOncology? Take a moment to find out more: #ASCO18
Logo
ASCO
ASCO
@ASCO 10 months
asco18 starts tomorrow follow our featured voices for on the ground expert insights
#ASCO18 starts tomorrow! Follow our Featured Voices for on-the-ground expert insights https://t.co/DFeoAVarDz
Bristol-Myers Squibb
bmsnews
we re researching the potential of combinations in immunooncology as we work to address cancer from all angles
We're researching the potential of combinations in #ImmunoOncology as we work to address cancer from all angles. Find out more: #ASCO18
Logo
Peter Loftus
Loftus
@Loftus 10 months
in the era of personalized medicine do big clinical trials still matter via wsj lucettelagnado asco18
In the era of personalized medicine, do big clinical trials still matter? https://t.co/UG8eC887vB via @WSJ @LucetteLagnado #ASCO18
Logo
ASCO
ASCO
@ASCO 10 months
follow our asco18 featured voices for live updates amp expert insights from the meeting
Follow our #ASCO18 Featured Voices for live updates & expert insights from the meeting: https://t.co/DFeoAVarDz
Total(1) => 0.16646504402161 f_f_QM(2) => 0.15897488594055 indS(2) => 0.010484218597412 indM(2) => 0.14841794967651 indM_1(2) => 0.022432088851929 indM_2(2) => 0.0010180473327637 indM_4(2) => 0.018926858901978 indM_5(2) => 0.027024030685425 indM_6(2) => 0.0029771327972412 indM_7(2) => 0.023806095123291 indM_8(2) => 0.0025949478149414 indM_9(2) => 0.0089578628540039 indM_10(2) => 0.0082168579101562 f_f_dT(59) => 0.0048575401306152 f_f_pTL(2) => 0.0019247531890869